Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - dystonia
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
A Group of Compounds that Activate AMP-activated protein kinase (AMPK) that may Treat Niemann-Pick Disease Type C (NPC)
This technology relates to the identification and use of a group of compounds that activate the AMP-activated protein kinase (AMPK) and also effectively reduce lysosomal cholesterol accumulation in patients with Niemann-Pick disease Type C (NPC). Clinical trials are currently underway to determine the efficacy of beta-cyclodextrin in treating patients...
Published: 10/28/2024
|
Inventor(s):
Zachery Caffall
,
Joseph Rittiner
,
Nicole Calakos
Keywords(s):
AMPK
,
C
,
Compositions
,
Disease
,
DISORDERS
,
Dystonia
,
Identifying
,
Methods
,
MODULATORS
,
Niemann
,
Pick
,
TREATING
,
treatment
,
TYPE
,
VEXXXX
,
WIXXXX
,
WKXXXX
,
XEXXXX
Category(s):
TherapeuticArea > Neurology
,
Application > Therapeutics
,
Application > Research Materials
Luteolin for treatment of neuromuscular movement disorder
dystonia
16 (DYT16)
Reference #: 01544 The University of South Carolina is offering licensing opportunities for Luteolin for treatment of neuromuscular movement disorder
dystonia
16 (DYT16) Background: DYT16 is a rare movement disorder, so the number of patients worldwide is small. However, Alzheimer's disease, Down syndrome are very prevalent and large numbers...
Published: 6/13/2024
|
Inventor(s):
Rekha Patel
Keywords(s):
anti-inflammatory pharma
,
dystonia
,
DYT16
,
inflammation
,
movement disorder
,
PACT
,
PKR
Category(s):
Biomedical and Life Sciences
,
Health Sciences